TScan Therapeutics
TCRX
TCRX
59 hedge funds and large institutions have $30.7M invested in TScan Therapeutics in 2025 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 19 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
50% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 20
51% less capital invested
Capital invested by funds: $62.9M → $30.7M (-$32.2M)
Holders
59
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$623K | |
| 2 | +$450K | |
| 3 | +$444K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$424K |
| 5 |
Two Sigma Investments
New York
|
+$335K |
Top Sellers
| 1 | -$3.52M | |
| 2 | -$1.96M | |
| 3 | -$1.65M | |
| 4 |
Morgan Stanley
New York
|
-$900K |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
-$802K |
